Chairman and Chief Executive Officer
Mr. Hirao has served as our Chairman and Chief Executive Officer since June 1, 2015. He previously served as business development manager of FUJIFILM’s pharmaceutical division from 2013 to 2015, where he had responsibility for the M&A transactions and licensing activities in the global markets. At FUJIFILM headquarters, he held international leadership and management roles for global business operations, including the non-destructive test business director of the industrial products division from 2010 to 2013 and senior operations manager for business development and global governance of the electronic materials division from 2005 to 2010. Between 1998 and 2005 he held various project management roles at the corporate planning division in connection with FUJIFILM Second Foundation. Mr. Hirao earned his B.A. from the Keio University in Tokyo and his M.B.A. from the University of Wisconsin-Madison. He completed the University of Tokyo Executive Management Program in 2012. From January 2012 to May 2015, Mr. Hirao was the secretary general of the Japan Netherlands Society, established in 1912, which contributes to the mutual understanding of the cultures between Japan and the Netherlands in cooperation with the Netherlands Embassy in Japan.
President and Chief Operating Officer
Dr. Nuwaysir has served as our President and Chief Operating Officer (COO) since May, 2015. He previously served as Vice President of Research and Development, Manufacturing and Quality Systems and COO at CDI from 2008 to 2015. He is a founder and has served as Vice-Chairman and Director of Invenra, a Wisconsin-based early stage company developing technology for biopharmaceutical discovery, since its inception in 2011. He previously served as Senior Vice President of Program Management at Roche NimbleGen from 2007 to 2008. Prior to this, he was Vice President of Business Development at NimbleGen Systems, Inc. from 2003 to 2007 and held various scientific and managerial roles at NimbleGen Systems from 2000 to 2003, including Molecular Research and Development Group Leader and Senior Manager of Technical and Client Services. Prior to NimbleGen Systems he held a Postdoctoral Fellowship with the National Institute of Environmental Health Sciences within the National Institutes of Health, a Postdoctoral Fellowship at the University of North Carolina-Chapel Hill and a research position at EI DuPont de Nemours Stine-Haskell Laboratory. He earned his B.A. from the University of Delaware and his Ph.D. in Molecular and Environmental Toxicology with a focus in Oncology from the University of Wisconsin-Madison in the McArdle Laboratory for Cancer Research.
Chief Technology Officer
Mr. Okada has served as FCDI’s Chief Technology Officer since October 1, 2015. He previously served as manager of FUJIFILM’s Healthcare Business Development Office from 2009 to 2015, where he had responsibility for Intellectual Property (IP) management in the fields of pharmaceuticals, cosmetics, functional foods and regenerative medicine. In conjunction with the strategic expansion of FUJIFILM’s business, he was in charge of IP due diligence in mergers and acquisitions and licensing opportunities. Before he joined FUJIFILM in 2006, he worked for Asahi Kasei Corporation, where he was in charge of business development and licensing activities for the pharmaceutical division, technology scouting for its U.S. subsidiary, IP prosecution and legal searching for the IP department and its U.S. affiliated law firm, and manufacturing development of cell culture in its research laboratory. Mr. Okada earned a B.S. in Agriculture from the University of Tokyo and a Bachelor of Laws from Meiji University.